Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity

Evaluation of potential vascular injury is an essential part of the safety study during pharmaceutical development. Vascular liability issues are important causes of drug termination during preclinical investigations. Currently, preclinical assessment of vascular toxicity primarily relies on the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Chengyi, Cunningham, Nathan J., Zhang, Mao, Wu, Joseph C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006367/
https://www.ncbi.nlm.nih.gov/pubmed/33790786
http://dx.doi.org/10.3389/fphar.2021.613837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006367/
https://www.ncbi.nlm.nih.gov/pubmed/33790786
http://dx.doi.org/10.3389/fphar.2021.613837

Ejemplares similares